Personalized evaluation for chest pain effective, may eliminate unnecessary testing

Corporate businessmen working on tablet at office

For people with stable chest pain, a personalized “precision” testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease when compared to usual care, according to late-breaking science presented today at the American Heart Association’s Scientific Sessions 2022. The meeting, held in person in Chicago and virtually, Nov. 5–7, 2022, is a global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.

The whodunnit fun returns in Rian Johnson’s ‘Glass Onion: A Knives Out Mystery’ Trailer

Previous article

Diabetes medicine decreases cardiovascular risk in adults with chronic kidney disease

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations